Moderna China Biopharmaceutical Headquarters and Production Base (Shanghai)

Products：304 Stainless Steel Coil/Sheet

Quantity: 820 tons

Project location: Xinzhuang Industrial Zone, Minhang District, Shanghai

Date: 2023.11

Project Name: Moderna China Biopharmaceutical Headquarters and Production Base

Project Positioning: A leading global R&D and production base for mRNA vaccines and drugs, and a significant foreign investment project in China's biopharmaceutical sector.

Environmental Requirements: The production area must meet extremely high cleanliness standards. Pipelines and structural components must possess excellent chemical corrosion resistance to withstand frequent cleanroom disinfection and chemical cleaning.

II. Shandong Runhai Steel Supply Solution

For the specific application scenarios in the biopharmaceutical industry, Shandong Runhai Steel provides a customized stainless steel product portfolio: 316 stainless steel (plates/pipes), 304 stainless steel (profiles/plates), and customized surface treatments.

III. Technical Highlights and Quality Commitment

1. Material purity and composition control; 2. Excellent corrosion resistance; 3. Precise specification delivery.

IV. Cooperation Value

1. Compliance Guarantee: Shandong Runhai Steel's products fully comply with the cleanliness standards for biopharmaceutical construction, helping the project successfully pass relevant GMP environmental validation.

2. Supply Chain Stability: During peak project periods, Shandong Runhai Steel ensured zero-delay supply of critical materials thanks to its strong warehousing and logistics capabilities.

3. Brand Value Enhancement: Providing services to Moderna, a leading international biopharmaceutical giant, further demonstrates Shandong Runhai Steel's competitive strength in the high-end specialty steel market.

From precision pharmaceutical laboratories to large-scale production workshops, Shandong Runhai Steel, with its high-quality 304/316 stainless steel products, has built a robust "corrosion-resistant barrier" for Moderna's China base. In the future, the company will continue to deepen its presence in high-tech industries such as biopharmaceuticals, providing more professional and reliable steel solutions.